C&EN

Chemical & Engineering News (C&EN) is a weekly publication produced by the American Chemical Society, offering valuable insights and updates in chemistry and chemical engineering. The magazine covers a wide range of topics, including the latest news and research, job opportunities, industry developments, government policies, and funding information. Both the print and digital editions are accessible to those with a national membership in the American Chemical Society. Additionally, the front section of the magazine is available online for free, while a subscription is necessary to access the complete content. Readers can also find exclusive online features and searchable archives of past issues.

National, Trade/B2B

English

Magazine

Outlet metrics

Domain Authority

Ranking

Global

N/A

Country

N/A

Articles

Field trial success for fighting banana weevils with fungal compounds

1 week ago | cen.acs.org | Fintan Burke

Few things can strike fear into the heart of a banana farmer more than finding an infestation of the banana weevil. Females of this coffee bean-sized insect lay their eggs between the plant's leaves and stem; after hatching, the larvae can wreak havoc on crops. "Larvae feed [on] the banana stem tissues, and the plants are unable to maintain [an] upright position," says Federico López Moya, a biologist at the University of Alicante.
BioNTech to buy fellow German mRNA firm CureVac

2 weeks ago | cen.acs.org | Laura Howes

The German mRNA firm BioNTech has announced that it will buy local rival CureVac in an all-stock transaction that values CureVac at around $1.25 billion. Once complete, CureVac will be wholly absorbed into BioNTech. CureVac wasn't forced into this deal by a lack of cash, however. The company has approximately €438.3 million ($507.9 million) cash on its balance sheet, enough to tide it over until 2028, according to its first-quarter financial results published on May 20.
BMS-owned RayzeBio licenses Philochem asset for $350 million up front

2 weeks ago | cen.acs.org | Laura Howes

Radiopharmaceutical company RayzeBio, a wholly owned subsidiary of Bristol Myers Squibb, will license a therapeutic and diagnostic asset for prostate cancer from Philochem. The deal is worth $350 million up front, with another $1 billion in development, regulatory, and commercial milestones. For that sum, RayzeBio will get global rights to OncoACP3, a small-molecule ligand that targets acid phosphatase 3 (ACP3).
A new nitrogen allotrope has been created at last

2 weeks ago | cen.acs.org | Bethany Halford

Carbon is famous for its allotropes, including humble graphite, flashy diamond, and satisfyingly symmetrical buckminsterfullerene. But allotropes of nitrogen, carbon's neighbor in the periodic table, are rare and usually fleeting. Now chemists at Justus Liebig University Giessen have created and isolated the neutral nitrogen allotrope hexanitrogen, or N 6-a string of six nitrogen atoms held together by four double bonds and one single bond in the molecule's center.
Alexandra Navrotsky seeks to uncover chemistry on other planets

2 weeks ago | cen.acs.org | Rachel Brazil

Alexandra Navrotsky knows a lot about the little things. She is a leader in the field of nanogeoscience, which centers around how nanoparticles lead to mineral formation in geological systems. In over half a century of research, she has made major contributions in mantle mineralogy, deep earth geophysics, and the thermodynamics behind mineral formation. She even lent her name to a recently discovered mineral-navrotskyite ( J. Geosci. 2023, DOI: 10.3190/jgeosci.378).
LyondellBasell unloads struggling European plants

3 weeks ago | cen.acs.org | Alexander H. Tullo

Following a yearlong review of its struggling European olefin and polyolefin business, LyondellBasell Industries has decided to practically give away four European chemical facilities to Aequita, a private equity firm that specializes in industrial turnarounds.
Forget the kiln. Here's a laser

3 weeks ago | cen.acs.org | Prachi Patel

Spacecraft and nuclear reactors rely on ceramics that can withstand temperatures above 2,000 °C. But the traditional process to make these specialty ceramics requires heating the raw materials in a furnace, burning time and energy. Researchers have now made an ultra-high-temperature ceramic (UHTC) in minutes by blasting its liquid precursor with a laser ( J. Am. Ceram. Soc. 2025, DOI: 10.1111/jace.20650).
Stronger and longer bioluminescence for viral detection

3 weeks ago | cen.acs.org | Helen Albert

Since the COVID-19 pandemic, many point-of-care diagnostic tests have reached the market, but despite this, many have only limited accuracy. "One major problem with almost all of these rapid tests is the sensitivity and specificity of these assays, especially when you're dealing with samples with a clinically relevant, low amount of the target virus," explains Hadi Shafiee, whose team develops new diagnostic tools at Harvard Medical School.
New method recycles lithium-iron-phosphate batteries cheaply

3 weeks ago | cen.acs.org | Sam Lemonick

Carmakers are quickly adopting the newest generation of rechargeable lithium-ion batteries, which are cheaper than their predecessors. But recycling lithium from the lithium-iron-phosphate (LFP) cathodes in these cells may not be economically viable using existing methods. A team of researchers says its new electrochemical approach could be a solution ( ACS Energy Letters, 2025, DOI: 10.1021/acsenergylett.5c01087).
Taurine is not a biomarker for aging after all

3 weeks ago | cen.acs.org | Laura Howes

The amino acid taurine is one of the building blocks of the proteins in our bodies and plays multiple other roles in biology. And while previous research has suggested that low levels of taurine may signal-or even drive-aging, a new longitudinal study by Rafael de Cabo and his team at the US National Institute on Aging (NIA) says the answer is more complicated ( Science 2025, DOI: 10.1126/science.adl2116). In 2023 a team led by Vijay K.